Role of PLZF as a tumor suppressor in prostate cancer

  • Jin Y
  • Nenseth H
  • Saatcioglu F
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

// Yang Jin 1 , Hatice Zeynep Nenseth 2 and Fahri Saatcioglu 1, 2 1 Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway 2 Department of Biosciences, University of Oslo, Oslo, Norway Correspondence to: Yang Jin, email: yangj@ibv.uio.no Fahri Saatcioglu, email: fahris@ibv.uio.no Keywords: promyelocytic leukemia zinc finger, prostate cancer, tumor suppressor, androgens Received: March 16, 2017      Accepted: July 12, 2017      Published: August 02, 2017 ABSTRACT The promyelocytic leukemia zinc finger (PLZF), also known as ZBTB16 (Zinc Finger And BTB Domain Containing 16), is a transcription factor involved in the regulation of diverse biological processes, including cell proliferation, differentiation, organ development, stem cell maintenance and innate immune cell development. A number of recent studies have now implicated PLZF in cancer progression as a tumor suppressor. However, in certain cancer types, PLZF may function as an oncoprotein. Here, we summarize our current knowledge on the role of PLZF in various cancer types, in particular prostate cancer, including its deregulation, genomic alterations and potential functions in prostate cancer progression.

Cite

CITATION STYLE

APA

Jin, Y., Nenseth, H. Z., & Saatcioglu, F. (2017). Role of PLZF as a tumor suppressor in prostate cancer. Oncotarget, 8(41). https://doi.org/10.18632/oncotarget.19813

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free